JOSÉ LUIS PABLOS ÁLVAREZ-rekin lankidetzan egindako argitalpenak (9)

2022

  1. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  2. Shorter telomere length is associated with COVID-19 hospitalization and with persistence of radiographic lung abnormalities

    Immunity and Ageing, Vol. 19, Núm. 1

2021

  1. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

    International Journal of Infectious Diseases, Vol. 105, pp. 487-494

  2. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study

    International Journal of Infectious Diseases, Vol. 105, pp. 319-325

  3. SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 6, pp. 1258-1262

2019

  1. Lamin A/C deficiency in CD4+ T-cells enhances regulatory T-cells and prevents inflammatory bowel disease

    Journal of Pathology, Vol. 249, Núm. 4, pp. 509-522

2015

  1. Macrophages from the synovium of active rheumatoid arthritis exhibit an activin a-dependent pro-inflammatory profile

    Journal of Pathology, Vol. 235, Núm. 3, pp. 515-526

2005

  1. Analysis of vascular endothelial growth factor (VEGF) functional variants in rheumatoid arthritis

    Human Immunology, Vol. 66, Núm. 8, pp. 864-868

1995

  1. Polymorphism of the heat-shock protein gene Hsp70-2in systemic lupus erythematosus

    Rheumatology, Vol. 34, Núm. 8, pp. 721-723